ETC
BSX icon

Evercore Trust Company’s Boston Scientific BSX Stock Holding History

Evercore Trust Company’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,203,320
Closed -$327M – 7
2017
Q3 		$327M Sell
11,203,320
-415,653
-4% -$11.5M 0.94% 13
2017
Q2 		$322M Sell
11,618,973
-186,488
-2% -$4.95M 0.98% 16
2017
Q1 		$294M Sell
11,805,461
-412,627
-3% -$10M 0.91% 16
2016
Q4 		$264M Sell
12,218,088
-167,624
-1% -$3.66M 0.85% 17
2016
Q3 		$295M Buy
12,385,712
+33,379
+0.3% +$796K 0.96% 16
2016
Q2 		$289M Sell
12,352,333
-214,949
-2% -$4.65M 0.92% 14
2016
Q1 		$236M Sell
12,567,282
-17,442
-0.1% -$306K 0.77% 17
2015
Q4 		$232M Sell
12,584,724
-329,633
-3% -$5.91M 0.85% 13
2015
Q3 		$212M Buy
+12,914,357
New +$221M 0.81% 14

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Evercore Trust Company's BSX Position: Q4 2017 in Review

Evercore Trust Company sold out of Boston Scientific (BSX) in Q4 2017, closing a stake of 11,203,320 shares — an estimated $327M sold.

Evercore Trust Company first reported a position in BSX in Q3 2015 and held it in 9 quarters. The position peaked at $327M in Q3 2017. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • Evercore Trust Company reported no remaining Boston Scientific position as of Q4 2017 after selling out during the quarter.
  • Evercore Trust Company sold 11,203,320 Boston Scientific shares in Q4 2017, an estimated $327M.
  • Evercore Trust Company first reported a position in Boston Scientific in Q3 2015 and held it in 9 quarters.
  • Evercore Trust Company's Boston Scientific position peaked at $327M in Q3 2017.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on Evercore Trust Company's 13F filing for Q4 2017.